These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34290518)

  • 1. Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP.
    Ge H; Liu X; Gu W; Feng X; Zhang F; Han F; Qian Y; Jin X; Gao B; Yu L; Bao H; Zhou M; Li S; Jie Z; Wang J; Chen Z; Hang J; Zhang J; Zhu H
    J Inflamm Res; 2021; 14():3335-3348. PubMed ID: 34290518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease.
    Liu X; Ge H; Feng X; Hang J; Zhang F; Jin X; Bao H; Zhou M; Han F; Li S; Qian Y; Jie Z; Gu W; Gao B; Yu L; Wang J; Ji H; Zhang J; Zhu H
    Front Med (Lausanne); 2020; 7():572435. PubMed ID: 33381510
    [No Abstract]   [Full Text] [Related]  

  • 3. CODEXS: A New Multidimensional Index to Better Predict Frequent COPD Exacerbators with Inclusion of Depression Score.
    Deng D; Zhou A; Chen P; Shuang Q
    Int J Chron Obstruct Pulmon Dis; 2020; 15():249-259. PubMed ID: 32099350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Cumulative Illness Rating Scale (CIRS) in Estimating the Impact of Comorbidities on Chronic Obstructive Pulmonary Disease (COPD) Outcomes: A Pilot Study of the MACH (Multidimensional Approach for COPD and High Complexity) Study.
    Di Raimondo D; Pirera E; Pintus C; De Rosa R; Profita M; Musiari G; Siscaro G; Tuttolomondo A
    J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The associations between comorbidity and exacerbation risk in patients with chronic obstructive pulmonary disease].
    Huang YL; Mao B; Mim J; Li GH; Zheng YQ; Wu LH; Wang SJ; Qu B; Fu JJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 May; 41(5):349-354. PubMed ID: 29747278
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors for anxiety and its impacts on acute exacerbation in older patients with chronic obstructive pulmonary disease.
    Mou Y; Shan L; Liu Y; Wang Y; He Z; Li X; Zhu H; Ge H
    Front Med (Lausanne); 2024; 11():1340182. PubMed ID: 38646561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of comorbidity indices as predictive indicators for frequent severe chronic obstructive pulmonary disease exacerbations.
    Doğan Mülazimoğlu D; Bilgin B; Ayöz S; Arslan F; Şen E
    Tuberk Toraks; 2024 Mar; 72(1):16-24. PubMed ID: 38676591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
    J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study.
    Kim Y; Kim YJ; Kang YM; Cho WK
    BMC Pulm Med; 2021 May; 21(1):151. PubMed ID: 33957924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk Assessment of Acute Exacerbation in COPD Patients in the Context of Pulmonary Follow-Up Rehabilitation Based on the Prevalence and Severity of Comorbidities].
    Luu P; Tulka S; Knippschild S; Windisch W; Spielmanns M
    Pneumologie; 2021 Jul; 75(7):516-525. PubMed ID: 33540464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HUNT study: Association of comorbidity clusters with long-term survival and incidence of exacerbation in a population-based Norwegian COPD cohort.
    Vikjord SAA; Brumpton BM; Mai XM; Romundstad S; Langhammer A; Vanfleteren L
    Respirology; 2022 Apr; 27(4):277-285. PubMed ID: 35144315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining prognosis in acute exacerbation of COPD.
    Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.
    Jeong SH; Lee H; Carriere KC; Shin SH; Moon SM; Jeong BH; Koh WJ; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1857-65. PubMed ID: 27536097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD.
    Westerik JA; Metting EI; van Boven JF; Tiersma W; Kocks JW; Schermer TR
    Respir Res; 2017 Feb; 18(1):31. PubMed ID: 28166777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
    Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
    Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
    Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment and verification of risk prediction model of acute exacerbation of chronic obstructive pulmonary disease based on regression analysis].
    Wang M; Cai K; Shi D; Tu X; Zhao H; Li S; Li J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jan; 33(1):64-68. PubMed ID: 33565403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.